|
|
||||||||
Gastrointestinal Research Group, University of Calgary, Calgary, Alberta, Canada
Regulatory T cells (Tregs) play a fundamental role in regulating the immune system in health and disease. Considerable evidence exists demonstrating that transfer of Tregs can cure colitis and a variety of other inflammatory disorders. However, little is known about the effects of inflammation on resident Tregs. Mice (BALB/c or C57BL/6) treated with an intrarectal instillation of the haptenizing agent 2,4-dinitrobenzene sulfonic acid (DNBS) develop an acute inflammatory disease, the histopathology of which peaks at 3 days posttreatment and resolves spontaneously thereafter. In this study we demonstrate that DNBS (or oxazolone)-induced colitis causes a depletion of colonic Foxp3+ Tregs 8 days posttreatment, while the proportion of Foxp3+ cells in the ileum, mesenteric lymph nodes, and spleen remains unchanged. Replenishment of the colonic Treg population was associated with the reappearance of mucosal homing (
4β7+) CD4+Foxp3+ Tregs. Assessing the mechanism of local Treg depletion, we found no evidence to implicate cytokine-induced phenotypic switching in the Foxp3+ population or increased SMAD7 expression despite the essential role that TGF-β has in Foxp3+ Treg biology. Increased Fas ligand (FasL) expression was observed in the colon of colitic mice and in vitro stimulation with a Fas cross-linking Ab resulted in apoptosis of CD4+Foxp3+ but not CD4+Foxp3– cells. Furthermore, DNBS-induced colitis in Fas/FasL-deficient mice did not result in depletion of colonic Tregs. Finally, adoptively transferred synergic Fas–/– but not Fas+/+ Tregs were protected from depletion in the colon 8 days post-DNBS treatment, thus substantiating the hypothesis that inflammation-induced local depletion of Foxp3+ Tregs in the colon of mice occurs via Fas/FasL-mediated death.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported Natural Sciences and Engineering Research Council of Canada Grant 341924. D.M.M. is supported by a Canada Research Chair (Tier 1) and an Alberta Heritage Foundation for Medical Research Scientist Award. C.R. was a recipient of a Natural Sciences and Engineering Research Council of Canada studentship.
2 Address correspondence and reprint requests to Dr. Derek M. McKay, Gastrointestinal Research Group, Department of Physiology and Biophysics, HS-1877, University of Calgary, 3330 Hospital Drive Northwest, Calgary, Alberta, Canada T2N 4N1. E-mail address: dmckay{at}ucalgary.ca
3 Abbreviations used in this paper: Treg, regulatory T cell; CMF, Ca2+- and Mg2+-free; DNBS, 2,4-dinitrobenzene sulfonic acid; EtOH, ethanol; FasL, Fas ligand; IBD, inflammatory bowel disease; i.r., intrarectal; LPL, lamina propria lymphocyte; MLN, mesenteric lymph node.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |